Pages that link to "Q77375796"
Jump to navigation
Jump to search
The following pages link to Expression of hepatocyte growth factor (HGF) and HGF receptor (c-met) proteins in liver diseases: an immunohistochemical study (Q77375796):
Displaying 23 items.
- Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors (Q33769437) (← links)
- Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3 (Q34393166) (← links)
- Distribution of nitric oxide synthase in normal and cirrhotic human liver (Q34431148) (← links)
- The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis (Q35563524) (← links)
- Hepatic stellate cells: central modulators of hepatic carcinogenesis (Q35642468) (← links)
- Angiogenesis in chronic inflammatory liver disease (Q35762577) (← links)
- Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer (Q36075407) (← links)
- Dysregulation of growth factor signaling in human hepatocellular carcinoma. (Q36519010) (← links)
- Targeting the HGF-cMET Axis in Hepatocellular Carcinoma (Q36766188) (← links)
- Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapy (Q36828371) (← links)
- Cell biology is different in small volumes: endogenous signals shape phenotype of primary hepatocytes cultured in microfluidic channels (Q37294097) (← links)
- Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives (Q37766798) (← links)
- Management of hepatocellular carcinoma: beyond sorafenib. (Q37995523) (← links)
- Role of cMET in the development and progression of colorectal cancer (Q38134309) (← links)
- Development of systemic therapy for hepatocellular carcinoma at 2013: updates and insights. (Q38201707) (← links)
- Identification of Proteins Indicating Radiation-induced Hepatic Toxicity in Cirrhotic Rats (Q42790403) (← links)
- Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases (Q42935424) (← links)
- Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy (Q45883662) (← links)
- Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma (Q48140297) (← links)
- Immunohistochemical analysis of atypical ductular reaction in the human liver, with special emphasis on the presence of growth factors and their receptors (Q49216523) (← links)
- Activation of c-Src gene product in hepatocellular carcinoma is highly correlated with the indices of early stage phenotype. (Q53396671) (← links)
- Hepatic expression of hepatocyte growth factor gene mRNA in acute liver failure (Q73298604) (← links)
- Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study (Q81455649) (← links)